We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients (AVERT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02048865
Recruitment Status : Completed
First Posted : January 29, 2014
Last Update Posted : November 20, 2018
Canadian Institutes of Health Research (CIHR)
Bristol-Myers Squibb
Information provided by (Responsible Party):
Ottawa Hospital Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 10, 2018
Actual Study Completion Date : October 19, 2018
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 December 19, 2022
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):